Tarsus Pharmaceuticals, Inc. - TARS

About Gravity Analytica
Recent News
- 05.01.2025 - Tarsus Q1 2025 Earnings Call
- 05.01.2025 - Tarsus Q1 2025 Earnings Call
- 04.24.2025 - Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
- 04.24.2025 - Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
- 04.22.2025 - Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting
- 04.22.2025 - Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting
Recent Filings
- 04.24.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 03.26.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.24.2025 - 144 Report of proposed sale of securities
- 03.20.2025 - 144 Report of proposed sale of securities
- 03.20.2025 - 144 Report of proposed sale of securities
- 03.20.2025 - 144 Report of proposed sale of securities
- 03.20.2025 - 144 Report of proposed sale of securities
- 03.20.2025 - 144 Report of proposed sale of securities
- 03.20.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.20.2025 - 4 Statement of changes in beneficial ownership of securities